A Cell Cycle Progression-Derived Gene Signature to Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma
CONCLUSION: Collectively, CCP-derived gene signature was a promising marker in prediction of survival outcomes and therapeutic responses for HCC patients.PMID:34721731 | PMC:PMC8553501 | DOI:10.1155/2021/1986159
Source: Disease Markers - Category: Laboratory Medicine Authors: Yongfeng Hui Junzhi Leng Dong Jin Di Liu Genwang Wang Qi Wang Yanyang Wang Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Fluvastatin | Genetics | Hepatocellular Carcinoma | Laboratory Medicine | Liver Cancer | Statin Therapy | Study